WT1 and renal cell carcinoma: Compelling emerging evidence demonstrating direct WT1 transcriptional activation by hypoxia-inducible factor 1 (HIF1) supports the notion of a physiological WT1-dependent adaptive mechanism to ischemia [109], while also bearing important implications regarding RCC pathogenesis.